Lipid nanoparticles have attracted significant interests in the last two decades, and have
achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the …

Worldwide nanotechnology development and application have fueled many scientific
advances, but technophilic expectations and technophobic demands must be …

Nanotechnology has made a great impact on the pharmaceutical, biotechnology, food, and
cosmetics industries. More than 40% of the approved drugs are lipophilic and have poor …

Lipid nanoparticles (LNPs) have gained prominence as primary carriers for delivering a
diverse array of therapeutic agents. Biological products have achieved a solid presence in …

Impaired wound healing is an encumbering public health issue that increases the demand
for develo** new therapies in order to minimize health costs and enhance treatment …

Antimicrobial resistance is one of the biggest threats to global health as current antibiotics
are becoming useless against resistant infectious pathogens. Consequently, new …

For many years, nanomedicine is pushing the boundaries of drug delivery. When applying
these novel therapeutics, safety considerations are not only a key concern when entering …

Chitosan-functionalized magnetite/poly (ε-caprolactone) nanoparticles were formulated by
interfacial polymer disposition plus coacervation, and loaded with gemcitabine. That …

Nanomedicine plays an essential role in develo** new therapies through novel drug
delivery systems, diagnostic and imaging systems, vaccine development, antibacterial tools …

Bioactive molecules and their effects have been influenced by their solubility and
administration route. In many therapeutic reagents, the performance of therapeutics is …